These findings affirm that targeting the cGAS-STING pathway with inhibitors could mitigate the inflammatory response associated with ischemia-reperfusion injury after stroke, providing a novel therapeutic strategy to enhance post-stroke recovery and reduce neuronal damage. This evidence concerns the gene CGAS and Stroke.